High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group
- PMID: 14645429
- DOI: 10.1200/JCO.2003.11.059
High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group
Abstract
Purpose: We present an update of a previously reported Late Effects Study Group cohort of 1,380 children with Hodgkin's disease (HD) diagnosed between 1955 and 1986 in patients aged 16 years or younger. We describe the pattern and incidence of subsequent neoplasms (SNs) occurring with extended follow-up.
Patients and methods: Median age at diagnosis of HD was 11.7 years (range, 0.3 to 16.9 years) and at last follow-up was 27.8 years. Median length of follow-up was 17.0 years.
Results: An additional 103 SNs were ascertained (total SNs = 212). The cohort was at an 18.5-fold increased risk of developing SNs compared with the general population (standardized incidence ratio [SIR], 18.5, 95% CI, 15.6 to 21.7). The cumulative incidence of any second malignancy was 10.6% at 20 years, increasing to 26.3% at 30 years; and of solid malignancies was 7.3% at 20 years, increasing to 23.5% at 30 years. Breast cancer was the most common solid malignancy (SIR, 56.7). Other commonly occurring solid malignancies included thyroid cancer (SIR, 36.4), bone tumors (SIR, 37.1), and colorectal (SIR, 36.4), lung (SIR, 27.3), and gastric cancers (SIR, 63.9). Risk factors for solid tumors included young age at HD and radiation-based therapy. Thirty-two patients developed third neoplasms, with the cumulative incidence approaching 21% at 10 years from diagnosis of second malignancy.
Conclusion: Additional follow-up of this large cohort of HD survivors documents an increasing occurrence of known radiation-associated solid tumors, (breast and thyroid cancers), as well as emergence of epithelial neoplasms common in adults, (colon and lung cancers) at a younger age than expected in the general population, necessitating ongoing surveillance of this high risk population.
Comment in
-
The cost of surviving cancer.Nature. 2018 Nov;563(7731):S44-S45. doi: 10.1038/d41586-018-07362-5. Nature. 2018. PMID: 30429565 No abstract available.
Similar articles
-
Italian cancer figures, report 2013: Multiple tumours.Epidemiol Prev. 2013 Jul-Oct;37(4-5 Suppl 1):1-152. Epidemiol Prev. 2013. PMID: 24259384 English, Italian.
-
Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five Nordic countries. Association of the Nordic Cancer Registries and the Nordic Society of Pediatric Hematology and Oncology.J Clin Oncol. 1996 May;14(5):1442-6. doi: 10.1200/JCO.1996.14.5.1442. J Clin Oncol. 1996. PMID: 8622057
-
Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence.J Clin Oncol. 2000 Jun;18(12):2435-43. doi: 10.1200/JCO.2000.18.12.2435. J Clin Oncol. 2000. PMID: 10856104
-
Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort.J Clin Oncol. 2009 May 10;27(14):2356-62. doi: 10.1200/JCO.2008.21.1920. Epub 2009 Mar 2. J Clin Oncol. 2009. PMID: 19255307 Free PMC article. Review.
-
Second malignancies after childhood Hodgkin's disease. The Memorial Sloan-Kettering Cancer Center experience.Cancer. 1988 Oct 1;62(7):1364-70. doi: 10.1002/1097-0142(19881001)62:7<1364::aid-cncr2820620721>3.0.co;2-t. Cancer. 1988. PMID: 3046737 Review.
Cited by
-
Total Body Irradiation and Risk of Breast Cancer After Blood or Marrow Transplantation: A Blood or Marrow Transplantation Survivor Study Report.J Clin Oncol. 2020 Sep 1;38(25):2872-2882. doi: 10.1200/JCO.20.00231. Epub 2020 Jul 16. J Clin Oncol. 2020. PMID: 32673169 Free PMC article.
-
Radiotherapy and wound healing.Int Wound J. 2005 Jun;2(2):112-27. doi: 10.1111/j.1742-4801.2005.00079.x. Int Wound J. 2005. PMID: 16722862 Free PMC article. Review.
-
Chronic conditions in adult survivors of childhood cancer.Curr Oncol Rep. 2007 Nov;9(6):435-6. doi: 10.1007/s11912-007-0060-x. Curr Oncol Rep. 2007. PMID: 17991349 No abstract available.
-
Proton therapy in the most common pediatric non-central nervous system malignancies: an overview of clinical and dosimetric outcomes.Ital J Pediatr. 2019 Dec 27;45(1):170. doi: 10.1186/s13052-019-0763-2. Ital J Pediatr. 2019. PMID: 31881905 Free PMC article. Review.
-
Long-term risk for subsequent leukemia after treatment for childhood cancer: a report from the Childhood Cancer Survivor Study.Blood. 2011 Jun 9;117(23):6315-8. doi: 10.1182/blood-2011-02-335158. Epub 2011 Apr 15. Blood. 2011. PMID: 21498675 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical